No significant effect of metoclopramide on misonidazole elimination in man.
作者信息
Williams K M, Begg E J, Wade D N, O'Shea K
出版信息
Br J Clin Pharmacol. 1983 Mar;15(3):390-2. doi: 10.1111/j.1365-2125.1983.tb01519.x.
Abstract
摘要
相似文献
1
No significant effect of metoclopramide on misonidazole elimination in man.胃复安对人体内灭滴灵的清除没有显著影响。
Br J Clin Pharmacol. 1983 Mar;15(3):390-2. doi: 10.1111/j.1365-2125.1983.tb01519.x.
2
No significant effect of cimetidine on the pharmacokinetics of misonidazole in man.西咪替丁对人咪硝唑药代动力学无显著影响。
Br J Clin Pharmacol. 1983 May;15(5):575-6. doi: 10.1111/j.1365-2125.1983.tb02096.x.
3
Kinetics of misonidazole enantiomers.米索硝唑对映体的动力学
Clin Pharmacol Ther. 1984 Dec;36(6):817-23. doi: 10.1038/clpt.1984.262.
4
Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.苯妥英、苯巴比妥和维生素C对米索硝唑消除的影响。
Clin Pharmacol Ther. 1983 Mar;33(3):314-21. doi: 10.1038/clpt.1983.39.
5
Biliary and faecal excretion of misonidazole in man.人咪康唑的胆汁及粪便排泄
Br J Radiol. 1979 Oct;52(622):846-8. doi: 10.1259/0007-1285-52-622-846.
6
Kinetic aspects of misonidazole and its major metabolite in radiotherapy.米索硝唑及其主要代谢物在放射治疗中的动力学研究
Hum Toxicol. 1985 Jul;4(4):425-34. doi: 10.1177/096032718500400409.
7
Circadian changes in the elimination of misonidazole in mouse.小鼠体内米索硝唑消除的昼夜节律变化。
Res Commun Chem Pathol Pharmacol. 1983 Nov;42(2):331-4.
8
The role of dexamethasone in the modification of misonidazole pharmacokinetics.地塞米松在改变米索硝唑药代动力学中的作用。
Br J Cancer. 1983 Oct;48(4):553-7. doi: 10.1038/bjc.1983.228.
9
Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog.苯妥英钠对犬体内米索硝唑药代动力学的影响。
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):360-1.
10
Effects of cimetidine, antipyrine, and pregnenolone carbonitrile on misonidazole pharmacokinetics.
Cancer Treat Rep. 1983 Jul-Aug;67(7-8):723-5.
引用本文的文献
1
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学（第二部分）。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
2
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.甲硝唑及其他硝基咪唑类抗感染药物的临床药代动力学
Clin Pharmacokinet. 1992 Nov;23(5):328-64. doi: 10.2165/00003088-199223050-00002.
本文引用的文献
1
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.苯妥英钠可缩短人体中缺氧细胞放射增敏剂米索硝唑的半衰期：对可能降低毒性的意义。
Br J Cancer. 1980 Feb;41(2):302-4. doi: 10.1038/bjc.1980.43.
2
Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.放射增敏剂Ro 07-0582的临床试验：多次给药的经验
Br J Cancer. 1977 May;35(5):567-79. doi: 10.1038/bjc.1977.90.
3
Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.苯巴比妥和苯妥英预处理对苯妥英在小鼠体内药代动力学及米索硝唑毒性的影响。
Br J Cancer. 1979 Sep;40(3):335-53. doi: 10.1038/bjc.1979.187.
4
The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.米索硝唑的神经毒性及其与剂量、半衰期和血清浓度的关系。
Br J Cancer Suppl. 1978 Jun;3:268-70.
Zotero 插件